Literature DB >> 6207623

HLA-D clusters associated with DR2 and the definition of HLA-D"AZH": a new DR2 related HLA-D specificity in Israel.

N Cohen, A Amar, J R Oksenberg, C Brautbar.   

Abstract

In order to investigate the HLA-D clusters associated with DR2 in Israeli Jews, 40 DR2 positive unrelated individuals were studied with a panel of DR2 associated homozygous typing cells (HTC's) which detect the lymphocyte defined specificities HLA-Dw2, Dw12, Dw9 and D-WJR. The results confirmed the existence of two distinct HLA-D clusters associated with the same serologically defined DR2. Of 40 individuals 22.5% (9/40) were Dw2 and 50% (20/40) were Dw12 carriers. Yet, no HLA-D specificity could be assigned to the remaining 11 DR2 positive individuals. In the present study we have defined a unique DR2-associated Dw specificity, HLA-D"AZH". The donor of the HTC was of Moroccan origin and an offspring of a first cousin marriage. This cell was not typeable with the known DR2-associated homozygous typing cells nor with other HTC's which define the well established HLA-Dw1 to Dw11 specificities. It was shown to segregate with DR2 positive HLA haplotypes in family analysis and in a population study, typed out 7 of 11 unrelated DR2 positive, Dw blank individuals, thus identifying a unique and new HLA-D cluster provisionally designated D"AZH".

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207623     DOI: 10.1111/j.1399-0039.1984.tb00390.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.

Authors:  D Zeliszewski; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis.

Authors:  A Marcadet; C Massart; G Semana; R Fauchet; O Sabouraud; M Merienne; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Polymorphism of the HLA DR1 haplotype in the Israeli population investigated at the serological, cellular, and genomic levels.

Authors:  N Cohen; A Friedmann; F Szafer; A Amar; D Cohen; C Brautbar
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms.

Authors:  M P Font; L Gebuhrer; H Betuel; C Freidel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells.

Authors:  D Zeliszewski; G Sterkers; C Brautbar; H Betuel; Z Layrisse; J P Levy
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Structural and functional variability among DQ beta alleles of DR2 subtypes.

Authors:  B S Lee; J I Bell; N A Rust; H O McDevitt
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.

Authors:  N Cohen; C Brautbar; M P Font; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.

Authors:  D P Singal; B Reid; D Green; W G Bensen; M D'Souza
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.